Table 1 Participant Baseline Information
Patient Baseline Data (N = 342) | Pre-Pandemic Period (N = 201) | Pandemic Period (N = 141) | p-value | |
|---|---|---|---|---|
Characteristics | Mean ± Standard Deviation (S.D) | |||
Age | 31.78 ± 18.76 | 32.61 ± 18.65 | 30.59 ± 18.94 | 0.336 |
Gender | ||||
Males | 187(54.7%) | 104(51.7%) | 83(58.9%) | 0.193 |
Females | 155(45.3%) | 97(48.3%) | 58(41.1%) | |
Medical History | ||||
Comorbidities | ||||
Diabetes | 7(2%) | 3(1.5%) | 4(2.8%) | 0.087 |
Hypertension | 16(4.7%) | 7(3.5%) | 9(6.4%) | |
Malignancy | 10(2.9%) | 8(4%) | 2(1.4%) | |
Cardiovascular Disease | 7(2%) | 6(3%) | 1(0.7%) | |
COPD and Cardiovascular Disease | 3(0.9%) | 2(1%) | 1(0.7%) | |
Dyslipidemia | 14(4.1%) | 11(5.5%) | 3(2.1%) | |
Obesity | 3(0.9%) | 3(1.5%) | 0(0%) | |
Appendicitis | 7(2%) | 6(3%) | 1(0.7%) | |
Combined (Diabetes, Hypertension, Dyslipidemia) | 12(3.5%) | 6(3%) | 6(4.3%) | |
Familiar Mediterranean Fever (FMF) | 2(0.6%) | 1(0.5%) | 1(0.7%) | |
Other | 82(24%) | 54(26.9%) | 27(19.1%) | |
None | 179(52.3%) | 92(45.8%) | 86(61%) | |